Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products ...

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Each year, when temperatures drop and gatherings move indoors, we enter respiratory virus season. During this time, from ...

Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

In the post-pandemic era, vaccination for all kinds of diseases has become a hot-button issue, increasingly so with the confirmation ...

Arizona's flu season may have peaked, but the virus continues to cause illness. Here's a look at symptoms to watch for.

Report commissioned by pharmaceutical company GSK says ageing population means need for vaccination is growing ...

It is a descendant of the deadlier clade 1a strain of mpox, formerly known as monkeypox , which is estimated to kill up to 10 ...